Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases.
Lamberg T, Sipponen T, Valtanen S, Eklund KK, Mälkönen T, Aalto K, Mikola K, Kolho KL, Leinonen S, Isomäki P, Mäkinen H, Vidqvist KL, Kokko A, Huilaja L, Kyllönen M, Keskitalo P, Sard S, Vähäsalo P, Koskela R, Kröger L, Lahtinen P, Haapala AM, Korkatti K, Sokka-Isler T, Jokiranta TS; BLING Research Group. Lamberg T, et al. Autoimmunity. 2022 Aug;55(5):275-284. doi: 10.1080/08916934.2022.2067985. Epub 2022 Apr 28. Autoimmunity. 2022. PMID: 35481450
The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
Paltta J, Heikkilä HK, Pirilä L, Eklund KK, Huhtakangas J, Isomäki P, Kaipiainen-Seppänen O, Kristiansson K, Havulinna AS, Sokka-Isler T, Palomäki A; FinnGen investigators. Paltta J, et al. Scand J Rheumatol. 2023 Jan;52(1):1-9. doi: 10.1080/03009742.2021.1967047. Epub 2021 Oct 13. Scand J Rheumatol. 2023. PMID: 34643165 Free article. Review.
The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register.
Backström M, Salo H, Kärki J, Aalto K, Rebane K, Levälampi T, Grönlund MM, Kröger L, Pohjankoski H, Hietanen M, Korkatti K, Kuusalo L, Rantalaiho V, Huhtakangas J, Relas H, Pääkkö T, Löyttyniemi E, Sokka-Isler T, Vähäsalo P. Backström M, et al. Among authors: sokka isler t. Pediatr Rheumatol Online J. 2023 Apr 14;21(1):35. doi: 10.1186/s12969-023-00814-x. Pediatr Rheumatol Online J. 2023. PMID: 37060076 Free PMC article.
Initial presentation of early rheumatoid arthritis.
Weman L, Salo H, Kuusalo L, Huhtakangas J, Kärki J, Vähäsalo P, Backström M, Sokka-Isler T. Weman L, et al. Among authors: sokka isler t. PLoS One. 2023 Jul 6;18(7):e0287707. doi: 10.1371/journal.pone.0287707. eCollection 2023. PLoS One. 2023. PMID: 37410796 Free PMC article.
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.
Smolen JS, Collaud Basset S, Boers M, Breedveld F, Edwards CJ, Kvien TK, Miossec P, Sokka-Isler T, van Vollenhoven RF, Abadie EC, Bruyère O, Cooper C, Mäkinen H, Thomas T, Tugwell P, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Smolen JS, et al. Ann Rheum Dis. 2016 Jul;75(7):1268-71. doi: 10.1136/annrheumdis-2016-209429. Epub 2016 Apr 1. Ann Rheum Dis. 2016. PMID: 27037326 Free PMC article. Review.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.
Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D. Smolen JS, et al. Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25. Ann Rheum Dis. 2014. PMID: 24161836 Free PMC article.
31 results